Running Oak Capital
BSX icon

Running Oak Capital’s Boston Scientific BSX Stock Holding History

Running Oak Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.09M Buy
208,331
+14,449
+7% +$669K 1.5% 44
2026
Q2 		$8.27M Buy
+193,882
New +$10.5M 1.41% 49
2025
Q3 		– Sell
-1,986
Closed -$213K – 56
2025
Q2 		$213K Sell
1,986
-268
-12% -$27.1K 0.02% 56
2025
Q1 		$227K Sell
2,254
-169,085
-99% -$17M 0.03% 56
2024
Q4 		$15.3M Buy
171,339
+8,018
+5% +$706K 2% 6
2024
Q3 		$13.7M Buy
163,321
+3,653
+2% +$288K 1.85% 16
2024
Q2 		$12.3M Sell
159,668
-7,841
-5% -$574K 1.91% 7
2024
Q1 		$11.5M Buy
167,509
+13,634
+9% +$877K 1.84% 20
2023
Q4 		$8.9M Buy
153,875
+23,091
+18% +$1.23M 1.75% 36
2023
Q3 		$6.91M Buy
130,784
+1,717
+1% +$90K 1.77% 32
2023
Q2 		$6.98M Buy
+129,067
New +$6.74M 1.71% 40

Other funds holding BSX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Running Oak Capital's BSX Position: Q3 2026 in Review

Running Oak Capital increased its Boston Scientific (BSX) stake by 7.5% in Q3 2026, buying an estimated $669K and bringing the position to 208,331 shares worth $9.09M. The position accounts for 1.5% of the portfolio, ranked #44.

Running Oak Capital first reported a position in BSX in Q2 2023 and has held it in 11 quarters since. The position peaked at $15.3M in Q4 2024. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Running Oak Capital held 208,331 shares of Boston Scientific worth $9.09M as of Q3 2026.
  • Running Oak Capital bought 14,449 Boston Scientific shares in Q3 2026, an estimated $669K.
  • Boston Scientific made up 1.5% of Running Oak Capital's portfolio in Q3 2026, its #44 holding.
  • Running Oak Capital first reported a position in Boston Scientific in Q2 2023 and has held it in 11 quarters since.
  • Running Oak Capital's Boston Scientific position peaked at $15.3M in Q4 2024.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Running Oak Capital's 13F filing for Q3 2026, filed 4 Nov 2026.